Riskpilot← Back to searchSign inGet full accessPlan C Vård och Behandling AB
ABActiveOrg 5592185077Fricksgatan 1Other social work activities without accommodation n.e.c. · NACE 8899Est. 20193 employees
Revenue 2025
SEK 655K
EBITDA margin
22.0%
+523% vs 2024
Equity ratio
42.9%
Financial strength
Net profit 2025
SEK 117K
+445% vs 2024
| Revenue | SEK 655K | — |
| EBITDA | SEK 144K | +523% |
| Net profit | SEK 117K | +445% |
| Total assets | SEK 323K | +1192% |
| Equity | SEK 139K | +560% |
| Employees | 3 | — |
Legal name
Plan C Vård och Behandling AB
Org number
5592185077
Legal form
Aktiebolag
NACE code
8899 · Other social work activities without accommodation n.e.c.
Founded
13 september 2019
Share capital
SEK 25 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva vård och omsorg samt sociala tjänster.
Address
Fricksgatan 1
Email
info@plan-c.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 655 |
| Staff expenses | — | −0 | — | — | −215 |
| EBITDA | — | — | −15 | −34 | 144 |
| Depreciation & amort. | −0 | — | −0 | −0 | — |
| EBIT | 0 | 0 | −15 | −34 | 144 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | 0 | 0 | −15 | −34 | 144 |
| Tax | −0 | — | −0 | −0 | −27 |
| Net profit | 0 | 0 | −15 | −34 | 117 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 50 | 50 | 35 | 25 | 323 |
| Equity | 50 | 50 | 35 | 21 | 139 |
| Long-term debt | 0 | — | 0 | 0 | — |
| Short-term debt | 0 | 0 | 0 | 4 | 184 |
| Total debt | — | — | — | 4 | 184 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20212025
Equity ratio
42.9%
This company
38.2%
Market median
+12% vs market
20212025
Return on equity
84.6%
This company
18.4%
Market median
+360% vs market
20212025
Net profit margin
17.9%
This company
8.1%
Market median
+121% vs market
20212025
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20212025
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Chief Auditor | Chief Auditor | 2024 |
| Former (3) | ||
EL Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
CM Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
MR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Plan C Vård och Behandling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Engel Livaja | Chief Executive Officer | 0 companies |
| Cabdulmaaliki Maxamed | Chief Executive Officer | 0 companies |
| Elvedin Music | Chief Auditor | 0 companies |
| Mohamad Rabani | Deputy Chief Executive Officer | 0 companies |
| Miro Matanovic | Board of Directors | 0 companies |
| Alen Livaja | Deputy Board Member | 0 companies |
| Roman Livaja | Deputy Board Member | 0 companies |